Aadi Bioscience, Inc. (AADI) Reports Q3 Loss, Tops Revenue Estimates
Aerpio Pharmaceuticals(AADI) ZACKS·2024-11-06 23:10
Aadi Bioscience, Inc. (AADI) came out with a quarterly loss of $0.46 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.60 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this company would post a loss of $0.71 per share when it actually produced a loss of $0.54, delivering a surprise of 23.94%.Over the last four quarters, the company has surpassed consensus EPS estimates two times.Aadi Bioscience, which belongs to th ...